1210 ABT-267 COMBINED WITH PEGYLATED INTERFERON ALPHA-2A/RIBAVIRIN IN GENOTYPE 1 (GT1) HCV-INFECTED TREATMENT-NAIVE SUBJECTS: 12 WEEK ANTIVIRAL AND SAFETY ANALYSIS

Authors:
  • GSG.J. Sullivan
    G.J. Sullivan
  • MRM. Rodriques-Torres
    M. Rodriques-Torres
  • ELE. Lawitz
    E. Lawitz
  • FPF. Poordad
    F. Poordad
  • MKM. Kapoor
    M. Kapoor
  • ACA. Campbell
    A. Campbell
  • CSC. Setze
    C. Setze
  • WXW. Xie
    W. Xie
  • AKA. Khatri
    A. Khatri
  • EDE. Dumas
    E. Dumas
  • PKP. Krishnan
    P. Krishnan
  • TPT. Pilot-Matias
    T. Pilot-Matias

Abstract
No abstract available